Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease
Clinical trial NCT02447627 · COMPLETED
Trial details
- NCT number
- NCT02447627
- Sponsor
- Bioverativ Therapeutics Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-10-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.